Nurix Therapeutics, Inc. NRIX Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept nrix:DeferredTaxAssetsAccruedExpensesAndOtherLiabilities.
The official record: Nurix Therapeutics, Inc.’s 10-K, filed January 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s accrued expenses and other liabilities?
- Nurix Therapeutics, Inc. (NRIX) reported accrued expenses and other liabilities of $5.26M in Q3 2025.
- What does accrued expenses and other liabilities mean?
- The aggregate value of short-term obligations and accrued liabilities that are recognized for tax purposes but not yet settled in cash. This metric provides insight into the company's near-term operational liabilities and potential future tax deductions.